PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Quality of care measures improve performance

2013-03-05
(Press-News.org) Public reporting of how physicians and hospitals perform in quality of care measures leads to improved care for patients. A collaborative team of researchers led by Geoffrey C. Lamb, M.D., professor of internal medicine at the Medical College of Wisconsin, published their findings in the March 2013 edition of Health Affairs.

The researchers analyzed 14 publicly reported quality of care measures from 2004 to 2009 for the Wisconsin Collaborative for Healthcare Quality, a voluntary consortium of physician groups, and found that physician groups in the collaborative improved their performance during the study period on many measures.

Diabetes-related measures showed the most significant improvement, with three out of the six measures showing double-digit percentage gains. The other three measures showed improvement of two to nine percent. Blood pressure control improved by nine percent as well.

When asked about the public reporting and its effect on care, group practices indicated they were able to act on some, but not all, of the quality measures reported forcing them to prioritize their efforts.

"Our findings show that voluntary reporting of quality measures helps drive improvement for participants, which should lead to better healthcare for our patients," said Dr. Lamb. "Furthermore, these results suggest that large group practices are willing to engage in quality improvement efforts in response to that public reporting."

### Co-authors of the study are Maureen A. Smith, M.D., Ph.D., M.P.H., associate professor of population health sciences, family medicine and surgery at the University of Wisconsin School of Medicine and Public Health; William B. Weeks, M.D., M.B.A., professor of psychiatry and community and family medicine at the Geisel School of Medicine at Dartmouth University; and Christopher Queram, M.A., president and CEO of the Wisconsin Collaborative for Healthcare Quality.


ELSE PRESS RELEASES FROM THIS DATE:

Prospective study finds many children with retinoblastoma can safely forego adjuvant chemotherapy

2013-03-05
In this News Digest: Summary of a study being published online March 4, 2013 in the Journal of Clinical Oncology, reporting that in certain children with retinoblastoma, adjuvant chemotherapy can be avoided, without risking disease worsening or relapse. The findings will help decision-making about adjuvant treatment and therapy selection for patients with low- , intermediate-, and high-risk retinoblastoma affecting only one eye Quote for attribution to ZoAnn Eckert Dreyer, MD, American Society of Clinical Oncology Cancer Communications Committee member and pediatric ...

Brain adds cells in puberty to navigate adult world

2013-03-05
The brain adds new cells during puberty to help navigate the complex social world of adulthood, two Michigan State University neuroscientists report in the current issue of the Proceedings of the National Academy of Sciences. Scientists used to think the brain cells you're born with are all you get. After studies revealed the birth of new brain cells in adults, conventional wisdom held that such growth was limited to two brain regions associated with memory and smell. But in the past few years, researchers in MSU's neuroscience program have shown that mammalian brains ...

Early antiretroviral treatment reduces viral reservoirs in HIV-infected teens

2013-03-05
A study led by University of Massachusetts Medical School professor and immunologist Katherine Luzuriaga, MD, and Johns Hopkins Children's Center virologist Deborah Persaud, MD, highlights the long-term benefits of early antiretroviral therapy (ART) initiated in infants. The study, presented on March 4 at the 20th annual Conference on Retroviruses and Opportunistic Infections (CROI) in Atlanta, shows that ART administered in early infancy can help curtail the formation of hard-to-treat viral sanctuaries — reservoirs of "sleeper" cells responsible for reigniting infection ...

Discovery of 'executioner' protein opens door to new options for stroke ALS, spinal cord injury

Discovery of executioner protein opens door to new options for stroke ALS, spinal cord injury
2013-03-05
Oxidative stress turns a protein that normally protects healthy cells into their executioner, according to a study released today in the Proceedings of the National Academy of Sciences journal. Alvaro Estevez, an associate professor at the University of Central Florida's College of Medicine, led the multi-university team that made the discovery, which could eventually help scientists develop new therapies to combat a host of conditions from stroke to Lou Gehrig's disease Researchers have long known that oxidative stress damages cells and results in neurodegeneration, ...

'OK' contact lenses work by flattening front of cornea, not the entire cornea...

2013-03-05
Philadelphia, Pa. (March 04, 2013) - A contact lens technique called overnight orthokeratology (OK) brings rapid improvement in vision for nearsighted patients. Now a new study shows that OK treatment works mainly by flattening the front of the cornea, reports a recent study, "Posterior Corneal Shape Changes in Myopic Overnight Orthokeratology", appearing in the March issue of Optometry and Vision Science, official journal of the American Academy of Optometry. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health. "This study appears ...

UCSB physicists make discovery in the quantum realm

UCSB physicists make discovery in the quantum realm
2013-03-05
(Santa Barbara, Calif.) –– Physicists at UC Santa Barbara are manipulating light on superconducting chips, and forging new pathways to building the quantum devices of the future –– including super-fast and powerful quantum computers. The science behind tomorrow's quantum computing and communications devices is being conducted today at UCSB in what some physicists consider to be one of the world's top laboratories in the study of quantum physics. A team in the lab of John Martinis, UCSB professor of physics, has made a discovery that provides new understanding in the quantum ...

60 percent loss of forest elephants in Africa confirmed

2013-03-05
NEW YORK (EMBARGOED UNTIL March 4, 2013, 5 PM U.S. Eastern Time) — African forest elephants are being poached out of existence. A study just published in the online journal PLOS ONE shows that across their range in central Africa, a staggering 62 percent of all forest elephants have been killed for their ivory over the past decade. "The analysis confirms what conservationists have feared: the rapid trend towards extinction – potentially within the next decade – of the forest elephant," says Dr. Samantha Strindberg of the Wildlife Conservation Society (WCS), one of the ...

Functional electrical stimulation cycling promotes recovery in chronic spinal cord injury

2013-03-05
VIDEO: In FES cycling, small electrical pulses are applied to the paralyzed muscles of an individual, stimulating the muscles to cycle on a stationary recumbent bicycle. The repetitive activity simulates movement... Click here for more information. (Baltimore, MD) – A new study by Kennedy Krieger Institute's International Center for Spinal Cord Injury (Epub ahead of print) finds that long-term lower extremity functional electrical stimulation (FES) cycling, as part of a rehabilitation ...

Daily-use HIV prevention approaches prove ineffective among women in NIH study

2013-03-05
Three antiretroviral-based strategies intended to prevent HIV infection among women did not prove effective in a major clinical trial in Africa. For reasons that are unclear, a majority of study participants—particularly young, single women—were unable to use their assigned approaches daily as directed, according to findings presented today by one of the study's co-leaders at the Conference on Retroviruses and Opportunistic Infections (CROI) in Atlanta. The Vaginal and Oral Interventions to Control the Epidemic (VOICE) study, or MTN 003, was designed to evaluate the ...

Study shows mirabegron effective and well tolerated for overactive bladder

2013-03-05
New York, NY, March 4, 2013 – In a new phase III trial mirabegron, a β3-adrenoceptor agonist, given once daily for 12 weeks, reduced the frequency of incontinence episodes and number of daily urinations, and improved urgency and nocturia in adults with overactive bladder (OAB) compared to those in a placebo group. The incidence of common adverse events (hypertension, urinary tract infection, headache, nasopharyngitis) was similar in the mirabegron and placebo groups in this study. Rates of dry mouth and constipation were similar in the drug and placebo groups. The ...

LAST 30 PRESS RELEASES:

It takes a village: Chimpanzee babies do better when their moms have social connections

From lab to market: how renewable polymers could transform medicine

Striking increase in obesity observed among youth between 2011 and 2023

No evidence that medications trigger microscopic colitis in older adults

NYUAD researchers find link between brain growth and mental health disorders

Aging-related inflammation is not universal across human populations, new study finds

University of Oregon to create national children’s mental health center with $11 million federal grant

Rare achievement: UTA undergrad publishes research

Fact or fiction? The ADHD info dilemma

Genetic ancestry linked to risk of severe dengue

Genomes reveal the Norwegian lemming as one of the youngest mammal species

Early birds get the burn: Monash study finds early bedtimes associated with more physical activity

Groundbreaking analysis provides day-by-day insight into prehistoric plankton’s capacity for change

Southern Ocean saltier, hotter and losing ice fast as decades-long trend unexpectedly reverses

Human fishing reshaped Caribbean reef food webs, 7000-year old exposed fossilized reefs reveal

Killer whales, kind gestures: Orcas offer food to humans in the wild

Hurricane ecology research reveals critical vulnerabilities of coastal ecosystems

Montana State geologist’s Antarctic research focuses on accumulations of rare earth elements

Groundbreaking cancer therapy clinical trial with US Department of Energy’s accelerator-produced actinium-225 set to begin this summer

Tens of thousands of heart attacks and strokes could be avoided each year if cholesterol-lowering drugs were used according to guidelines

Leading cancer and metabolic disease expert Michael Karin joins Sanford Burnham Prebys

Low-intensity brain stimulation may restore neuron health in Alzheimer's disease

Four-day school week may not be best for students, review finds

Using music to explore the dynamics of emotions

How the brain supports social processing as people age

Túngara frog tadpoles that grew up in the city developed faster but ended up being smaller

Where there’s fire, there’s smoke

UCLA researchers uncover key mechanism of brain repair in vascular dementia, revealing promising therapeutic target

Why Human empathy still matters in the age of AI

COVID-19 and cognitive change in a community-based cohort

[Press-News.org] Quality of care measures improve performance